|
Varanasi/Chennai:
Experts across India on Friday said that the issue of superbug of
Indian origin, or New Delhi metallo-beta-lactamase (NDM-1), is
unnecessarily being fuelled as similar resistances have been found
in other parts of the world.
"I don't think that there is a basis to all of these rumors.
Resistance phenomena was always there and there are different
mechanism, one after the other mechanisms are discovered," said
Dr. M.R Sen, Professor of Microbiology at the Banaras Hindu
University (BHU).
Supriya Upadhyay, a microbiology research scholar
at the BHU, said that there is no need to panic and treatment for
the same was available.
"All enzymes of Betalactom group fail in front of this (Superbug).
But more combination therapies are there, TG cycling lots of
aminoglycocides,... combinations with which it can be treated. So
there is nothing to panic because these mechanisms have come before
also, not in India but in other countries who have claimed that
India is responsible for spreading this," Upadhyay added.
Meanwhile, in Chennai, researchers said that NDM-1 has been going on
for a while now and the superbug is not confined to a certain area.
"Just to give us awareness, that's OK, this type of resistance is
there and we have to find ways to tackle it, but it is not confined
only to this particular geographic location. It is also present in
other parts so since there is a lot of intercontinental or other
travel by a lot of people these days. So this type of transmission
could happen from any country to any other country," said Dr. Padma
Krishnan, Professor, Department of Microbiology, Madras University.
In a study published in The Lancet Infectious Diseases journal on
Wednesday, it was found NDM-1 was becoming more common in
Bangladesh, India, and Pakistan and was also imported back to
Britain in patients returning after treatment.
(ANI)
|
Comment on this article